The rising use of biosimilars is expected to result in the near doubling of the size of pharma cold chain logistics business over the next three years. Pharma IQ spoke with Javier Gomez-Contreras Supply Chain BGx LATAM of GSK about the prospects for vaccine distribution as the industry serves the rise in demand.
Download this piece to learn more about:
How cold chain processes have to be adapted when transporting vaccines
What the biggest challenges for the future of vaccine distribution are
Which new technologies can support how these vaccines are transported
Please note: That all fields marked with an asterisk (*) are required.
*Processing your payment may take a moment. Please click submit payment only once, and do not refresh this page. Doing so may result in your credit card being charged more than once.
Your experience on this site will be improved by allowing cookies.